• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
TECHNOLOGY TRANSFER

Innovator Profile

Photo of Brian Geiss.

Brian Geiss, PhD

Associate Professor, Department of Microbiology, Immunology, and Pathology

Primary College

  • College of Veterinary Medicine and Biomedical Sciences

Innovator Links

  • Google Scholar
  • PubMed
  • Faculty Profile
  • Other

Innovator Bio

My group is interested in the molecular virology and biochemistry of mosquito-borne Arboviruses. Arboviruses, including flaviviruses and alphaviruses, are the most prevalent mosquito-borne viral pathogens worldwide. For example, approximately 2/3 of the world’s population is at risk for infection by dengue virus, yellow fever virus, West Nile virus, or related flaviviruses. Arbovirus infection can result in disease symptoms ranging from mild flu-like illness to debilitating encephalitis or death. Because arboviral infection is such a large health and socio-economic problem globally, my research has focused on finding ways to reduce human disease caused by these mosquito-borne viruses. We have a number of collaborative basic and translational research projects that involve flaviviruses (dengue, West Nile, and yellow fever) and alphaviruses (Sindbis, Chikungunya).

Innovator Technologies

Five test tubes filled with orange, yellow, green, blue, and purple liquids with bubbles, representing laboratory experiments.

Lab-Built Zika Virus Plasmids for Faster Research and Discovery

Test tube for COVID-19

Monoclonal Antibodies Targeting SARS-VOC-2 Nucleocapsid Protein

Gloved scientist with COVID samples

Plasmid to Produce Recombinant SARS-CoV-2 Nucelocapsid Protein

Automated Disposable Enzyme-Linked Immunosorbent Assay For At Home Detection

Electrochemical Capillary-driven Immunoassay and System

Nuclease Protection ELISA Assay for Diagnosis of Infectious Disease

Reagents

Sindbis Virus Replicons and Plasmids: Used to Study a Wide Range of Cellular Processes

CSU-Affiliated Startups

Innovator Patents

WO2018195399A1: Paper-based assay for antimicrobial resistance.

US20140004590A1: Thioxothiazolidine inhibitors.

Patent list generated using Google Patents.
Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect